Medifast Inc risk profile
57 Elevated one input has moved against it
Measured 1 September 2026 from MED's filed statements. Recomputed nightly.
57 (Elevated), driven by Competitive position at 77, over 5 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 51 | Elevated | Volatile | One-year price volatility — 52.6% |
| Operating pressure | 52 | Elevated | Easing | Operating-margin drift — -15.2 percentage points |
| Cash conversion | 64 | Stretched | Worsening | Capital spending against operating cash — 0.82x |
| Leverage and coverage | 1 | Contained | Easing | Current ratio — 4.69x |
| Competitive position | 77 | Stretched | Stable | Revenue-growth gap against peers — -78.0 percentage points |
| Concentration | Reads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company. | |||
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.